Leading Proxy Advisory Firm ISS Recommends MindMed Shareholders Vote FOR...
MindMed to Participate at Upcoming Investor Conferences...
MindMed Releases Investor Presentation Highlighting How the Company is...
MindMed Publishes Report by Leading FDA Experts Validating MindMed’s...
MindMed to Present Data on the Preclinical Activity of MM-402 at the...
You are leaving MindMed and will be automatically redirected to ${url} in a moment.
Change your mind?
Return to Mindmed